跳轉至內容
Merck
全部照片(1)

Key Documents

PHR1761

Supelco

奈韦拉平相关化合物B

Pharmaceutical Secondary Standard; Certified Reference Material

同義詞:

5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one, 5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-b:2’,3’-e][1,4] DIAZEPIN-6-ONE

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C12H10N4O
CAS號碼:
分子量::
226.23
分類程式碼代碼:
41116107
NACRES:
NA.24

等級

certified reference material
pharmaceutical secondary standard

品質等級

agency

traceable to USP 1460736

API 家族

nevirapine

CofA

current certificate can be downloaded

包裝

pkg of 50 mg

技術

HPLC: suitable
gas chromatography (GC): suitable

應用

pharmaceutical (small molecule)

格式

neat

儲存溫度

2-30°C

InChI

1S/C12H10N4O/c1-7-4-6-14-11-9(7)15-12(17)8-3-2-5-13-10(8)16-11/h2-6H,1H3,(H,15,17)(H,13,14,16)

InChI 密鑰

RKCRKBSFEVQVSX-UHFFFAOYSA-N

尋找類似的產品? 前往 產品比較指南

一般說明

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Nevirapine is found to be the first antiretroviral agent and selective non-competitive inhibitor of the reverse transcriptase, widely used for the treatment of adults and adolescents affected with human immunodeficiency viruses (HIV).

應用

Nevirapine may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical samples using capillary zone electrophoresis method.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

分析報告

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

其他說明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

腳註

To see an example of a Certificate of Analysis for this material enter LRAA8554 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

象形圖

Skull and crossbones

訊號詞

Danger

危險聲明

防範說明

危險分類

Acute Tox. 3 Oral

儲存類別代碼

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Simultaneous determination of zidovudine and nevirapine in human plasma by RP-LC
Marchei E, et al.
Journal of Pharmaceutical and Biomedical Analysis, 29(6), 1081-1088 (2002)
Development and validation of a simple and rapid capillary zone electrophoresis method for determination of nnrti nevirapine in pharmaceutical formulations
Filho ZAL, et al.
Journal of the Brazilian Chemical Society, 22(10), 205-2012 (2011)
Development of a liposomal nanodelivery system for nevirapine
Ramana NL, et al.
Journal of Biomedical Science, 17(1), 57-57 (2010)

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務